Заключение. 
Непрошеные гости: влияние усиленного бактериального роста в тонком кишечнике на состояние питания

При высоком уровне настороженности, применяя дыхательный тест с лактулозой, избыточный бактериальный рост в тонком кишечнике может быть идентифицирован, как фактор вызывающий гастроинтестинальные расстройства и нарушения пищеварения. Эрадикация SIBO не приводит к драматическому улучшению клинических данных, но позволяет корректировать многообразные негативные влияния избыточно бактериального роста на пищеварение.

Литература

• 1. Mackowiak PA. The normal microbial flora. N Engl J Med, 1982; 307: 83−93.
• 2. Gorbach SL, Plaut AG, Nahas L, et al. Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology, 1967; 53: 856−867.
• 3. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol, 2003;98:412−419. 4. Toskes PP. Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med, 1993; 38: 387−407.
• 5. Vantrappen G, Janssens J, Coremans G, et al. Gastrointestinal motility disorders. Dig Dis Sci, 1986; 31: 5S-25S.
• 6. Pimentel M, Soffer EE, Chow EJ, et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci, 2002; 47: 2639−2643.
• 7. Rutgeerts P, Ghoos Y, Vantrappen G, et al. Ileal dysfunction and bacterial overgrowth in patients with Crohn’s disease. Eur J Clin Invest 1981; 11: 199−206.
• 8. Castiglione F, Del Vecchio Blanco G, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn’s disease. J Clin Gastroenterol, 2000; 31: 63−66.
• 9. Lembcke B, Kraus B, Lankisch PG. Small intestinal function in chronic relapsing pancreatitis. Hepatogastroenterology, 1985; 32: 149−151.
• 10. Rubinstein E, Mark Z, Haspel J, et al. Antibacterial activity of the pancreatic fluid. Gastroenterology, 1985; 88: 927−932.
• 11. Williams DA, Batt RM, McLean L. Bacterial overgrowth in the duodenum of dogs with exocrine pancreatic insufficiency. J Am Vet Med Assoc, 1987; 191: 201−206.
• 12. Lai D, Gorbach SL, Levitan R. Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance. Gastroenterology, 1972; 62: 275−279.
• 13. Correia JP, Garnel M, Monteiro E, et al. Bacteriology of the small intestine in cirrhotic subjects and its relation to malabsorption. Am J Gastroenterol, 1971; 56: 428−435.
• 14. Chang CS, Chen GH, Lien HC, et al. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 1998; 28: 1187−1190.
• 15. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 2003; 37: 343−350.
• 16. Bursztein-De Myttenaere S, Gil KM, Heymsfield SB, et al. Gastric emptying in humans: influence of different regimens of parenteral nutrition. Am J Clin Nutr, 1994;60:244−248.
• 17. Deitch EA, Xu D, Naruhn MB, et al. Elemental diet and IV-TPNinduced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg, 1995; 221: 299−307.
• 18. Alverdy JC, Aoys E, Moss GS. Total parenteral nutrition promotes bacterial translocation from the gut. Surgery, 1988; 104: 185−190.
• 19. Tabaqchali S, Hatzioannou J, Booth CC. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet, 1968; 2: 12−16.
• 20. Toskes PP, Giannella RA, Jervis HR, et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Lightand electronmicroscopic and histochemical studies. Gastroenterology, 1975; 68: 193−203.
• 21. Ament ME, Shimoda SS, Saunders DR, et al. Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterology, 1972; 63: 728−747.
• 22. Layer P, von der Ohe MR, Holst JJ, et al. Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology, 1997; 112: 1624−1634.
• 23. Lin HC, Zhao XT, Wang L. Jejunal brake: inhibition of intestinal transit by fat in the proximal small intestine. Dig Dis Sci, 1996; 41: 326−329.
• 24. Lin HC, Zhao XT, Wang LJ. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci, 1997; 42: 19−25.
• 25. Read NW, McFarlane A, Kinsman RI, et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology, 1984; 86: 274−280.
• 26. Spiller RC, Trotman IF, Higgins BE, et al. The ileal brake—inhibition of jejunal motility after ileal fat perfusion in man. Gut, 1984; 25: 365−374.
• 27. Oumi M, Yamamoto T. A scanning electron microscope study on the effects of different bile salts on the epithelial lining of jejunal mucosa. Med Electron Microsc, 2000; 33: 11−15.
• 28. Giannella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology, 1974; 67: 965−974.
• 29. Jones EA, Craigie A, Tavill AS, et al. Protein metabolism in the intestinal stagnant loop syndrome. Gut, 1968; 9: 466−469.
• 30. Rutgeerts L, Mainguet P, Tytgat G, et al. Enterokinase in contaminated small-bowel syndrome. Digestion, 1974; 10: 249−254.
• 31. King CE, Toskes PP. Small intestine bacterial overgrowth. Gastroenterology, 1979; 76: 1035−1055.
• 32. Welkos SL, Toskes PP, Baer H. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology, 1981; 80: 313−320.
• 33. Drude Jr. RB, Hines Jr. C. The pathophysiology of intestinal bacterial overgrowth syndromes. Arch Intern Med, 1980; 140: 1349−1352.
• 34. Riepe SP, Goldstein J, Alpers DH. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest, 1980; 66: 314−322.
• 35. Toskes PP, Donaldson RM. Enteric bacterial flora and bacterial overgrowth. In: Sleisinger & Fortrand’s Gastrointestinal Diseases, Fifth Edition. Eds., Feldman M, Scharschmitt BF, Sleisinger MH, 1993; 1106−1117.
• 36. Egger G, Kessler JI. Clinical experience with a simple test for the detection of bacterial deconjugation of bile salts and the site and extent of bacterial overgrowth in the small intestine. Gastroenterology, 1973; 64: 545−551.
• 37. Davidson GP, Robb TA, Kirubakaran CP. Bacterial contamination of the small intestine as an important cause of chronic diarrhea and abdominal pain: diagnosis by breath hydrogen test. Pediatrics, 1984; 74: 229−235.
• 38. Rumessen JJ, Gudmand-Hoyer E, Bachmann E, et al. Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14CD-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol, 1985; 20: 1267−1275.
• 39. Tillman R, King C, Toskes P. Continued experience with the xylose breath test: Evidence that the small bowel culture as a gold standard for bacterial overgrowth may be tarnished. Gastroenterology, 1981; 80: 1304.
• 40. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med, 1969; 281: 122−127.
• 41. Levitt MD, Donaldson RM. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med, 1970; 75: 937−945.